nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review
|
Shahmohammadi, Sareh |
|
2018 |
22 |
C |
p. 22-26 |
artikel |
2 |
A survey of dietary characteristics in a large population of people with multiple sclerosis
|
Fitzgerald, Kathryn C. |
|
2018 |
22 |
C |
p. 12-18 |
artikel |
3 |
A systematic review about the epidemiology of primary progressive multiple sclerosis in Latin America and the Caribbean
|
Rojas, Juan Ignacio |
|
2018 |
22 |
C |
p. 1-7 |
artikel |
4 |
B cell depleting therapy for multiple sclerosis overlapping with neuromyelitis optica spectrum disorder
|
Lu, Tingting |
|
2018 |
22 |
C |
p. 83-85 |
artikel |
5 |
Characterisation of cardiac autonomic function in multiple sclerosis based on spontaneous changes of heart rate and blood pressure
|
Shirbani, Fatemeh |
|
2018 |
22 |
C |
p. 120-127 |
artikel |
6 |
Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY)
|
Cohan, Stanley L. |
|
2018 |
22 |
C |
p. 27-34 |
artikel |
7 |
Comment on Y.D. Fragoso et al.: “Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod” Multiple Sclerosis and Related Disorders 2017
|
Akgün, Katja |
|
2018 |
22 |
C |
p. 68-69 |
artikel |
8 |
Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: The first report from Iran
|
Barzegar, Mahdi |
|
2018 |
22 |
C |
p. 161-165 |
artikel |
9 |
Could antiretrovirals be treating EBV in MS? A case report
|
Drosu, Natalia C. |
|
2018 |
22 |
C |
p. 19-21 |
artikel |
10 |
Diagnosing and caring for MS in Haiti
|
Waubant, Emmanuelle |
|
2018 |
22 |
C |
p. A1-A2 |
artikel |
11 |
Dysregulation of NRXN1 by mutant MIR8485 leads to calcium overload in pre-synapses inducing neurodegeneration in Multiple sclerosis
|
Kattimani, Yogita |
|
2018 |
22 |
C |
p. 153-156 |
artikel |
12 |
Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis
|
Suleiman, Leena |
|
2018 |
22 |
C |
p. 103-107 |
artikel |
13 |
Evolution of multiple sclerosis prevalence and phenotype in Latin America
|
Negrotto, L. |
|
2018 |
22 |
C |
p. 97-102 |
artikel |
14 |
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test
|
Coghe, Giancarlo |
|
2018 |
22 |
C |
p. 8-11 |
artikel |
15 |
Forkhead box C1 gene variant causing glaucoma and small vessel angiopathy can mimic multiple sclerosis
|
Avasarala, Jagannadha R. |
|
2018 |
22 |
C |
p. 157-160 |
artikel |
16 |
Frequent retinal ganglion cell damage after acute optic neuritis
|
Brandt, Alexander U. |
|
2018 |
22 |
C |
p. 141-147 |
artikel |
17 |
Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility study
|
D'hooghe, Marie |
|
2018 |
22 |
C |
p. 90-96 |
artikel |
18 |
Impulsivity traits in patients with multiple sclerosis
|
Toro, Jaime |
|
2018 |
22 |
C |
p. 148-152 |
artikel |
19 |
Letter to the editor to the paper: “Acute and long-term effects of fingolimod on heart rhythm and heart rate variability in patients with multiple sclerosis”
|
Ziemssen, Tjalf |
|
2018 |
22 |
C |
p. 57-58 |
artikel |
20 |
Lifestyle factors and multiple sclerosis: A population-based incident case-control study
|
Abdollahpour, Ibrahim |
|
2018 |
22 |
C |
p. 128-133 |
artikel |
21 |
Matching-adjusted comparisons demonstrate better clinical outcomes with SC peginterferon beta-1a every two weeks than with SC interferon beta-1a three times per week
|
Coyle, Patricia K. |
|
2018 |
22 |
C |
p. 134-138 |
artikel |
22 |
New clinical implications of anti-myelin oligodendrocyte glycoprotein antibodies in children with CNS demyelinating diseases
|
Di Pauli, Franziska |
|
2018 |
22 |
C |
p. 35-37 |
artikel |
23 |
Optical coherence tomography as a biomarker of neurodegeneration in multiple sclerosis: A review
|
Alonso, Ricardo |
|
2018 |
22 |
C |
p. 77-82 |
artikel |
24 |
Physiotherapeutic interventions in multiple sclerosis across Europe: Regions and other factors that matter
|
Martinková, Patrícia |
|
2018 |
22 |
C |
p. 59-67 |
artikel |
25 |
Pneumonitis secondary to alemtuzumab in a patient with multiple sclerosis – A non-infectious cause of breathlessness
|
Whiteside, D. |
|
2018 |
22 |
C |
p. 139-140 |
artikel |
26 |
Preliminary investigation of cognitive function in aged multiple sclerosis patients: Challenges in detecting comorbid Alzheimer’s disease
|
Roy, Shumita |
|
2018 |
22 |
C |
p. 52-56 |
artikel |
27 |
Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: Multi-center, controlled trial
|
Ozakbas, Serkan |
|
2018 |
22 |
C |
p. 70-76 |
artikel |
28 |
Recommended outcome measures for inpatient rehabilitation of multiple sclerosis are not appropriate for the patients with substantially impaired mobility
|
Barin, Laura |
|
2018 |
22 |
C |
p. 108-114 |
artikel |
29 |
Recurrent pseudotumoral relapses in multiple sclerosis: a case report
|
Lebrato Hernández, Lucía |
|
2018 |
22 |
C |
p. 49-51 |
artikel |
30 |
Reply to: Comment on Y.D. Fragoso et al.: “Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod” [Mult. Scler. Relat. Disord. (2017)]
|
Fragoso, Yara Dadalti |
|
2018 |
22 |
C |
p. 166 |
artikel |
31 |
Response to letter to the editors
|
Birnbaum, Gary |
|
2018 |
22 |
C |
p. 86 |
artikel |
32 |
Severe CNS inflammation after discontinuation of natalizumab and start of daclizumab successfully treated with alemtuzumab
|
Hümmert, Martin W. |
|
2018 |
22 |
C |
p. 87-89 |
artikel |
33 |
Severe multiple sclerosis reactivation after gonadotropin treatment
|
Torkildsen, Øivind |
|
2018 |
22 |
C |
p. 38-40 |
artikel |
34 |
Spanish validation of a specific measure to assess work-related problems in people with multiple sclerosis: The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23)
|
Martínez-Ginés, María L. |
|
2018 |
22 |
C |
p. 115-119 |
artikel |
35 |
The protective effects of high-education levels on cognition in different stages of multiple sclerosis
|
Rimkus, Carolina de Medeiros |
|
2018 |
22 |
C |
p. 41-48 |
artikel |